
Profiter is an innovative AI-driven platform specialized in pharmaceutical logistics, designed to optimize inventory management by predicting demand, planning reorder, and designing warehouse strategies. It leverages advanced AI algorithms tailored to the pharmaceutical sector to improve supply chain efficiency, reduce stock levels, and minimize stockouts, delivering measurable performance improvements such as +75% process efficiency, -17% average stock levels, and -83% stockouts. The company operates primarily in Italy with offices in Bari and Milan, targeting pharmaceutical distributors, e-commerce, and the pharmaceutical industry, aiming to create sustainable production and consumption models while enhancing financial and environmental outcomes.

Profiter is an innovative AI-driven platform specialized in pharmaceutical logistics, designed to optimize inventory management by predicting demand, planning reorder, and designing warehouse strategies. It leverages advanced AI algorithms tailored to the pharmaceutical sector to improve supply chain efficiency, reduce stock levels, and minimize stockouts, delivering measurable performance improvements such as +75% process efficiency, -17% average stock levels, and -83% stockouts. The company operates primarily in Italy with offices in Bari and Milan, targeting pharmaceutical distributors, e-commerce, and the pharmaceutical industry, aiming to create sustainable production and consumption models while enhancing financial and environmental outcomes.
Sector: AI-driven pharmaceutical logistics and inventory management
Founded: 2021 (project origins 2019)
HQ: Bari, Italy (secondary hub in Milan)
Core product: SaaS platform for demand forecasting, replenishment planning, and warehouse optimization
Notable investors: Startup Wise Guys; TESISQUARE S.p.A.; Michele Palumbo
Pharmaceutical supply chain inefficiencies: demand forecasting, reorder planning, and warehouse strategy for distributors and pharmacies.
2021
DeepTech
Pre-seed round recorded in June 2022
“Includes Startup Wise Guys and TESISQUARE S.p.A.; individual investor Michele Palumbo also listed”